Literature DB >> 15585604

Safety of intravenous iron in clinical practice: implications for anemia management protocols.

George R Aronoff1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15585604     DOI: 10.1097/01.ASN.0000143815.15433.87

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  11 in total

Review 1.  On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery.

Authors:  Manuel Muñoz; José Antonio García-Erce; Jorge Cuenca; Elvira Bisbe; Enrique Naveira
Journal:  Blood Transfus       Date:  2011-11-30       Impact factor: 3.443

2.  Management of Iron Deficiency Anemia in Pregnancy in India.

Authors:  Rimpy Tandon; Arihant Jain; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-14       Impact factor: 0.900

3.  Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

4.  Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.

Authors:  Keiichi Sumida; Charles Dyer Diskin; Miklos Z Molnar; Praveen K Potukuchi; Fridtjof Thomas; Jun Ling Lu; Connie M Rhee; Elani Streja; Kunihiro Yamagata; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Am J Nephrol       Date:  2017-11-07       Impact factor: 3.754

Review 5.  Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.

Authors:  Alexander Neuwelt; Navneet Sidhu; Chien-An A Hu; Gary Mlady; Steven C Eberhardt; Laurel O Sillerud
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

6.  Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients.

Authors:  Tadao Akizawa; Keiko Tanaka-Amino; Tetsuro Otsuka; Yusuke Yamaguchi
Journal:  Am J Nephrol       Date:  2021-10-08       Impact factor: 3.754

7.  Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients.

Authors:  Hassan N Ibrahim; Robert N Foley; Rui Zhang; David T Gilbertson; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 8.237

Review 8.  Intravenous iron in inflammatory bowel disease.

Authors:  Manuel Muñoz; Susana Gómez-Ramírez; José Antonio García-Erce
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

9.  Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.

Authors:  Toros Kapoian; Neeta B O'Mara; Ajay K Singh; John Moran; Adel R Rizkala; Robert Geronemus; Robert C Kopelman; Naomi V Dahl; Daniel W Coyne
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

Review 10.  Interpretation of the Kidney Disease: Improving Global Outcomes guidelines for iron therapy: commentary and emerging evidence.

Authors:  Jeffrey S Berns
Journal:  Clin Kidney J       Date:  2017-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.